Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity
- 1 April 2000
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 355 (9213), 1428-1429
- https://doi.org/10.1016/s0140-6736(00)02144-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.Journal of Clinical Oncology, 1998
- Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of prostatic bony metastases.The British Journal of Radiology, 1997
- Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrationsBone and Mineral, 1993
- A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone painRadiotherapy and Oncology, 1992
- Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastasesRadiotherapy and Oncology, 1986